Kiniksa Pharmaceuticals International, plc (KNSA)

Last Closing Price: 41.67 (2025-12-05)

Pre-Tax Profit Margin (Quarterly)

Pre-Tax Profit Margin: Earnings before taxes as a portion of total revenue. Calculated as: Pre-Tax Income / Total Revenues

Kiniksa Pharmaceuticals International, plc (KNSA) had Pre-Tax Profit Margin of 15.02% for the most recently reported fiscal quarter, ending 2025-09-30.

Figures for fiscal quarter ending 2025-09-30
Income Statement Financials
$180.85M
$18.43M
$20.26M
$160.60M
$156.83M
$24.02M
$3.14M
$27.16M
$27.16M
$18.43M
$18.43M
$18.43M
$18.43M
$24.02M
$24.41M
74.72M
80.03M
$0.25
$0.23
Balance Sheet Financials
$475.53M
$1.66M
$236.80M
$712.33M
$123.59M
--
$53.36M
$176.95M
$535.38M
$519.88M
$535.38M
75.42M
Cash Flow Statement Financials
$84.09M
$-118.18M
$25.36M
$183.58M
$174.86M
$-8.72M
$26.77M
--
--
Fundamental Metrics & Ratios
3.85
--
--
--
--
88.80%
13.28%
13.28%
--
Pre-Tax Profit Margin
15.02%
10.19%
$83.16M
--
--
--
0.25
0.49
3.50
25.75
3.44%
3.55%
2.59%
3.44%
$7.10
$1.04
$1.05